Latest (520) Full Text Articles (11656) Article Summary

print mdlinx article: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome

email mdlinx article: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome

save mdlinx article to my library: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome
Retina, 03/19/2012

Nielsen JS et al. – Long–term intravitreal anti–VEGF therapy with bevacizumab or ranibizumab is beneficial in treatment of choroidal neovascularization in ocular histoplasmosis syndrome.

► Click here to access PubMed, Publisher and related articles...

Currently, there are no available articles.

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.

Most Popular Physician Assistant Articles

Last month's top read Top Articles of 2012

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physician more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome Retina, 03/19/2012

Most Popular Physician Assistant Articles

Other Topics in Physician Assistant

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary To Ocular Histoplasmosis Syndrome
Retina, 03/19/2012